Scarica l'app Stockscreener
1.48
0.68%
0.01
Dopo l'orario di chiusura:
1.51
0.03
+2.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.47
Aprire:
$1.48
Volume 24 ore:
892.29K
Relative Volume:
0.60
Capitalizzazione di mercato:
$54.28M
Reddito:
$832.00K
Utile/perdita netta:
$-135.12M
Rapporto P/E:
-0.243
EPS:
-6.09
Flusso di cassa netto:
$-124.69M
1 W Prestazione:
+3.50%
1M Prestazione:
+11.28%
6M Prestazione:
-27.45%
1 anno Prestazione:
-83.44%
Intervallo 1D:
$1.461
$1.52
Intervallo di 1 settimana:
$1.3505
$1.52
Portata 52W:
$1.30
$9.10
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Nome
Inovio Pharmaceuticals Inc
Settore
Industria
Telefono
(858) 410-3134
Indirizzo
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Confronta INO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
1.48 | 74.91M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 60.58B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 54.99B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 42.25B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.93B | 3.81B | -644.79M | -669.77M | -6.24 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Piper Sandler | Overweight |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2024-01-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-11-09 | Downgrade | Maxim Group | Buy → Hold |
| 2022-11-01 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-19 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-01-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-12-29 | Ripresa | Jefferies | Hold |
| 2021-09-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-24 | Iniziato | Jefferies | Hold |
| 2021-03-23 | Iniziato | BofA Securities | Neutral |
| 2021-02-12 | Iniziato | Oppenheimer | Outperform |
| 2020-11-17 | Downgrade | ROTH Capital | Neutral → Sell |
| 2020-11-10 | Aggiornamento | ROTH Capital | Sell → Neutral |
| 2020-09-28 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-07-01 | Downgrade | Maxim Group | Buy → Hold |
| 2020-07-01 | Downgrade | ROTH Capital | Neutral → Sell |
| 2020-06-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | Downgrade | Stifel | Buy → Hold |
| 2020-05-21 | Iniziato | The Benchmark Company | Buy |
| 2020-04-30 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-03-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | Iniziato | ROTH Capital | Buy |
| 2018-02-15 | Reiterato | Maxim Group | Buy |
| 2017-10-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-09-06 | Iniziato | Citigroup | Buy |
| 2017-06-08 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | Reiterato | Maxim Group | Buy |
| 2017-03-16 | Aggiornamento | Maxim Group | Hold → Buy |
| 2017-03-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
Mostra tutto
Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie
Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy? - sharewise.com
How Inovio Pharmaceuticals Inc. stock performs during market volatilityOversold Bounce Stock Play Ideas Gain Attention - metal.it
INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025 - MarketScreener
INOVIO To Report Second Quarter 2025 Financial Results On August 12, 2025 - Barchart.com
Inovio Pharmaceuticals Inc expected to post a loss of 61 cents a shareEarnings Preview - TradingView
What institutional investors are buying Inovio Pharmaceuticals Inc. stockBuild a diversified portfolio for steady growth - Jammu Links News
What is Inovio Pharmaceuticals Inc. company’s growth strategyDiscover high-impact stocks for growth - Jammu Links News
Why is Inovio Pharmaceuticals Inc. stock attracting strong analyst attentionAchieve fast wealth growth with smart picks - Jammu Links News
What catalysts could drive Inovio Pharmaceuticals Inc. stock higher in 2025Free AI-Backed Trading Signals - Jammu Links News
What makes Inovio Pharmaceuticals Inc. stock price move sharplyFree Consultation - Jammu Links News
How many analysts rate Inovio Pharmaceuticals Inc. as a “Buy”Get exclusive access to professional stock picks - Jammu Links News
When is Inovio Pharmaceuticals Inc. stock expected to show significant growthExplosive portfolio gains - Jammu Links News
What is the risk reward ratio of investing in Inovio Pharmaceuticals Inc. stockIdentify winners with top-tier analysis - Jammu Links News
What are Inovio Pharmaceuticals Inc. company’s key revenue driversBuild a portfolio that outperforms the market - Jammu Links News
Should I hold or sell Inovio Pharmaceuticals Inc. stock in 2025Build a portfolio for long-term financial success - Jammu Links News
What are the latest earnings results for Inovio Pharmaceuticals Inc.Invest smarter with expert stock picks - Jammu Links News
How does Inovio Pharmaceuticals Inc. compare to its industry peersExceptional profit margins - Jammu Links News
What is the dividend policy of Inovio Pharmaceuticals Inc. stockAmplify your gains with low-risk picks - Jammu Links News
Is Inovio Pharmaceuticals Inc. stock overvalued or undervaluedChart Pattern Updates For Fast Growth - jammulinksnews.com
Inovio Pharmaceuticals Inc. Recovery Hinges on Volume BreakoutSecure Capital Picks With Upside Potential Tracked - metal.it
DNA Nanotechnology Market Is Booming So Rapidly 2025-2032 - openPR.com
What Technical Tools Say About Inovio Pharmaceuticals Inc. RecoveryCommunity Verified Stock Suggestions Drive Volume - beatles.ru
Inovio Is Banking On DNA Medicine Milestones To Turn Things Around - Finimize
Cancer Vaccine Market Research Service Featuring the Top 5 Developers and Pipeline Activities - GlobeNewswire Inc.
Lassa Fever Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Inovio Pharma - The Globe and Mail
Stocks in play: SECURE Waste Infrastructure Corp. - The Globe and Mail
Published on: 2025-07-29 04:14:56 - metal.it
Published on: 2025-07-28 23:09:09 - metal.it
How does Inovio Pharmaceuticals Inc. generate profit in a changing economySky-high return potential - Jammu Links News
Does Inovio Pharmaceuticals Inc. stock perform well during market downturnsInvest confidently with professional market insights - Jammu Links News
What are the technical indicators suggesting about Inovio Pharmaceuticals Inc.Free Risk Assessment Services - Jammu Links News
Inovio Pharmaceuticals Inc Azioni (INO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.40%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):